Ubicom Holdings. Inc. · TSE:3937
Ubicom — FY2024 Q3 Earnings Presentation
32 slides from Ubicom's earnings presentation, Feb 6, 2025
Slide 1: FY2024 Q3 Financial Results Materials
Ubicom Holdings, Inc. (Prime Market of TSE: 3937) FY2024 Q3 Financial Results Materials February 6, 2025
Slide 2: Table of Contents
Table of Contents 01 Overview of Consolidated Financial Results (P/L) for FY2024 Q3 P.3 02 Medical Business P.7 03 Technology Consulting Business P.18 04 Dividend Policy P.25 05 Appendix P.27 © Ubicom Holdings, Inc. 2
Slide 3: Overview of Consolidated Financial Results (P/L) for 3Q of FY2024
Overview of Consolidated Financial Results (P/L) for 3Q of FY2024 Sales・Operating income・Ordinary income・Net income All sections reached record highs in the third quarter. Net income reached 694 million yen in the fiscal year, achieving approximately 70％ of the 1,000 million yen budget. This improve
Slide 4: Consolidated Results: Trends in Sales and Operating Income
Consolidated Results：Trends in Sales and Operating Income 3Q of FY2024 (Sales) 3Q of FY2024 (Operating Income) Accumulated Third Quarter Accumulated Third Quarter (Unit : million yen) (百万円) Operating income ratio 5,000 1,800 YoY comparison Operating income ratio YoY comparison 3.4％ incr. 9.5％ incr.
Slide 5: Overview by Segment for 3Q of FY2024 (Business Performance and Ratios)
Overview by Segment for 3Q of FY2024 (Business Performance and Ratios) ➀ Medical Business ～Provision of management supporting solutions for medical institutions～ Business segments ② Technology Consulting Business ～Lab-based partnership and offshore transfer consulting～ Medical business Technology co
Slide 6: Our Business Model: A Model for Resolving Social Issues in Japan
Our Business Model: A Model for Resolving Social Issues in Japan, A Developed Country Facing Challenges 01 Medical Business 02 Technology Consulting Business Reforming the workstyle of Addressing the shortage medical professionals of 787,000* IT engineers Improving the profitability Mission by 2030
Slide 7: Medical Business
Medical Business 7
Slide 8: Medical Business: Overview by Segment for 3Q of FY2024
Medical Business： Overview by Segment for 3Q of FY2024 (Business Performance) Both sales and operating income reached record highs due to the expansion of stock related to the package sales of the Mighty series utilizing the AI × Subscription model, as well as the increase in average user spending d
Slide 9: User's Trend of the Core Solution Mighty Series
AI×Subscription Model User’s Trend of the Core Solution「Mighty」Series The application of work style reforms for medical doctors in April 2024 has led to an acceleration of digital transformation in the medical industry. While focusing on converting existing users, the number of users is steadily inc
Slide 10: Approaches in expanding profits in the Medical Business
Approaches in expanding profits in the Medical Business Acquire new users for the “Mighty” series and promote the replacement of the new product to current users. Replacement of the new Acquiring New Users product for Current Users N/A Replace target （MCEX・Cloud） Expanding 16,775 inst. 5,000 inst. e
Slide 11: Promotion of replacing existing users
Promotion of replacing existing users Enhancing MightyChecker® EX Sales and Accelerating the Second Growth Phase Through Strengthened Collaboration with the Japan Medical Association Switching Existing Users from the Old Model (MightyChecker®for ORCA) to the New Model (MightyChecker® EX) The number
Slide 12: Measures to Expand Orders
「Mighty QUBE® Hybrid」 「MightyChecker® EX」 Measures to Expand Orders 12
Slide 13: Introduction of Core Products of the Mighty Series
AI×Subscription Model Introduction of Core Products of the Mighty Series Electronic Medical Record (EMR) Linked System System for supporting medical doctors in inputting disease names in electronic medical records and checking inputted items by utilizing AI ⚫ Linked with electronic medical records,
Slide 14: Marketing strategy: Measures for the increase of orders for Mighty QUBE Hybrid
Marketing strategy: Measures for the increase of orders for "Mighty QUBE® Hybrid" MightyChecker®既存取引のある中小病院向け電子カルテメーカーに対するクロスセル施策 MightyChecker® Cross-Selling Initiative for EMR Manufacturers Serving Existing Small and Medium-sized Hospitals ＜Installation of EMR We will target small and medium-sized
Slide 15: Developing Multiple New Platforms for the Second Growth Phase
Developing Multiple New Platforms for the Second Growth Phase Expanding new platform business by utilizing Clients & Medical Data base and Intellectual properties. We aim to further develop a new recurring model to increase sales and profits. New target markets in Stable Earnings the second growth p
Slide 16: Installation Results and Progress of Insurance Knowledge Platform
Installation Results and Progress of Insurance Knowledge Platform A solution for the insurance industry to assist in improving the efficiency of claims payment operations, utilizing a proprietary medical database backed by a track record of providing services to more than 21,000 medical institution
Slide 17: Launch of Remote Service Platform
Launch of Remote Service Platform Launched our first remote service platform as an alliance with a major medical staffing company. Points ・ Contribution to sales expansion of MightyChecker® EX due to an increase in the number of medical institutions contracting to the health insurance claims online
Slide 18: Technology Consulting Business
Technology Consulting Business 18
Slide 19: Technology Consulting Business: Overview by Segment for 3Q of FY2024
Technology Consulting Business： Overview by Segment for 3Q of FY2024 (Business Performance) With the launch of new projects, including the APAMAN Group, and the resolution of delays in Sler-related projects that occurred in the previous Q3 due to external factors, operating income increased by appro
Slide 20: Technology Consulting Business: 3Q of FY2024 Trends in Operating Income
Technology Consulting Business：3Q of FY 2024 Trends in Operating Income 3Q of FY 2024 (Accumulated) 3Q of FY 2024 (Quarterly) (Unit : million yen) (Unit(百万円) : million yen) (百万円) Operating income ratio 250 Operating income ratio 500 YoY comparison YoY comparison 3.7％ incr. 12.8％ 11.9％ incr. 450 17.3
Slide 21: A new value and differentiation strategy created by Designed Lab-type Development
A new value and differentiation strategy created by the「Designed Lab-type Development」 【Risks and Concerns of Usual Offshore Development】 In case the of setting up an offshore base In case the of usual Lab-type development Client Client’s Site Offshore development company Client Lab model developmen
Slide 22: Implementing Multiple Measures to Increase Operating Income
Implementing Multiple Measures to Increase Operating Income （Technology Consulting Business） The 2nd Growth Phase（ Medium/Long-term Vision ） 10000 New Market and Measures to Improve Operating Margin 9000 ➀ ② ③ Up utilization rate Expansion business Launch by highly skilled consulting business Allian
Slide 23: Business Forecast
Business Forecast 23
Slide 24: Business Results and Promotion of Measures in the Second Growth Phase
Business Results and Promotion of Measures in the Second Growth Phase ① Operation of multiple new platforms (Medical Business) ② Full-scale launch of Mighty QUBE® Hybrid and MightyChecker® EX’s cross-selling (Medical Business) ③ Enhancement of sales for consulting in Japan through organizational ref
Slide 25: Dividend Policy
Dividend Policy 25
Slide 26: Dividend Policies for Enabling Shareholders to Share Benefits from Growth
Dividend Policies for Enabling Shareholders to Share Benefits from the Growth of Our Company 【Dividend Policies】 ➀ We aim to distribute profits to shareholders stably. ② To increase the dividend amount about three times from the previous fiscal year, while maintaining a good balance between the grow
Slide 27: Appendix
Appendix 27
Slide 28: Promotion of Our Group's Business That is Socially Meaningful
Promotion of Our Group’s Business That is Socially Meaningful Considering business and capital alliances with leading global companies for the second growth phase Provision of solutions that are beneficial to three things: workstyles reforms for medical Growing demand due to the doctors, which are b
Slide 29: ESG: For sustainable growth of business, society, and client companies
ESG：For sustainable growth of business, society, and client companies Goals Concrete Activities Related SDGs ・To make the electric power consumed at ・To reduce CO2 emissions E the head office 100% derived from renewable energy ・Global partnership ・Investment in equipment of subsidiaries in the Phili
Slide 30: Corporate Profile
Corporate Profile ■Corporate name: Ubicom Holdings, Inc. (Prime Market of TSE: 3937) ■Strategic markets: healthcare, finance, public services, automobiles, manufacturing, robotics, etc. ■Business description: Technology Consulting Business In order to solve the problem of shortage of IT engineers an
Slide 31: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements ▪ The materials and information provided in this announcement include forward-looking statements based on our current estimates and expectations at this point of time. ▪ Such forward-looking statements are subject to various risks and uncertaintie
Slide 32: © Ubicom Holdings, Inc.
Ubicom Holdings, Inc. y f was 32